Home › Funds › BECK MACK & OLIVER LLC › TEVA

BECK MACK & OLIVER LLC position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

BECK MACK & OLIVER LLC reported holding 1,057,375 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$35.8M, representing 0.75% of its reported portfolio and ranking #33 among its reported holdings. BECK MACK & OLIVER LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.06M sh
Reported value held$35.82M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BECK MACK & OLIVER LLC's TEVA position evolved

BECK MACK & OLIVER LLC first disclosed a stake in TEVA in Q3 2023 at 3,177,112 shares (US$32.4M). The position peaked in Q2 2026 at 1,057,375 shares, worth US$35.8M. Across 12 filings, BECK MACK & OLIVER LLC increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,057,375 shares valued at US$35.8M — an increase of 5,675 shares quarter over quarter.. Notable position changes include a 31% trim in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.18M $32.41M New
Q4 2023 2.43M $25.39M Reduce
Q1 2024 1.89M $26.72M Reduce
Q2 2024 1.31M $21.24M Reduce
Q3 2024 1.23M $22.23M Reduce
Q4 2024 1.20M $26.39M Reduce
Q1 2025 1.17M $17.99M Reduce
Q2 2025 1.10M $18.42M Reduce
Q3 2025 1.10M $22.16M Hold
Q4 2025 1.06M $32.97M Reduce
Q1 2026 1.05M $31.68M Hold
Q2 2026 1.06M $35.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has BECK MACK & OLIVER LLC held TEVA?

BECK MACK & OLIVER LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BECK MACK & OLIVER LLC's current position in TEVA?

As of Q2 2026, BECK MACK & OLIVER LLC holds 1.06M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $35.82M, representing 0.75% of its reported portfolio and ranking #33.

Has BECK MACK & OLIVER LLC been buying or selling TEVA?

In the latest 13F filing (Q2 2026), BECK MACK & OLIVER LLC increased its position in TEVA. The position peaked in Q2 2026 at 1.06M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.